Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human CCKBR Stable Cell Line

    [CAT#: S01YF-0923-PY56]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    CCKBR
    Target Family
    Cholecystokinin Family
    Target Protein Species
    Human
    Host Cell Type
    MCF-7;T47D;CHO-K1;HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    CNS Research
    Related Diseases
    Panic Disorder;Anxiety
    Gene ID
    Human: 887
    UniProt ID
    Human: P32239

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    Cholecystokinin B receptor (CCKBR) is primarily known for its role in the gastrointestinal system, where it mediates the effects of the hormone gastrin. This receptor plays a pivotal role in stimulating acid secretion in the stomach. Beyond its gastrointestinal functions, recent research has unveiled the potential of CCKBR in regulating blood pressure, particularly in the context of salt-sensitive hypertension. Moreover, the therapeutic potential of targeting CCKBR in cancer has been explored, with studies suggesting that modulating its activity can impact tumor growth and progression.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human CCKBR Stable Cell Line (S01YF-0923-PY56). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Gary (Verified Customer)

    How does CCKBR influence salt-sensitive hypertension? Mar 12 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Intestinal CCKBR plays a crucial role in regulating blood pressure. It has been found that the gastrin/CCKBR system in the intestine can ameliorate salt-sensitive hypertension by inhibiting the activity of the Na+/H+ exchanger 3 through a PKC-mediated pathway. Mar 12 2022

    chat Shirley (Verified Customer)

    What is the therapeutic potential of CCKBR in tumors? Jan 27 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    CCKBR has been identified as a potential target to improve the therapeutic efficacy of radiolabeled minigastrin analogues in CCKBR-positive cancers. This suggests that modulating CCKBR can enhance the treatment outcomes for certain types of cancers. Jan 27 2020

    Published Data

    Fig.1 The inhibitory impact of gastrin via CCKBR on estrogen receptor-positive breast cancer cells.

    The CCK-8 assay findings indicated that silencing of CCKBR effectively abrogated the suppressive influence exerted by gastrin on both MCF-7 and T-47D cell lines (*P < 0.05).

    Ref: Meng, Li-Li, et al. "Low serum gastrin associated with ER+ breast cancer development via inactivation of CCKBR/ERK/P65 signaling." BMC cancer 18.1 (2018): 1-14.

    Pubmed: 30115027

    DOI: 10.1186/s12885-018-4717-7

    Research Highlights

    Liu Y, et al. "Transcriptome profiling in rumen, reticulum, omasum, and abomasum tissues during ." Frontiers in veterinary science, 2023.
    The development of the four stomachs in yaks plays a crucial role in their overall health and performance; however, the specific molecular mechanisms responsible for this relationship remain largely unknown. To address this gap in knowledge, the current study systematically examined the mRNA expression patterns of the four stomachs (rumen, reticulum, omasum, and abomasum) at five different growth time points (0 day, 20 days, 60 days, 15 months, and 3 years). Results showed that the expression patterns of differentially expressed mRNAs (DEmRNAs) were unique at birth (0 d) but became more similar at 20 d and 60 d, with further similarity observed at 15 m and adulthood. The Abomasum exhibited a markedly different expression pattern compared to the Rumen, Reticulum, and Omasum. Using the Short Time-series Expression Miner (STEM) analysis, the study found that multi-model spectra were significantly enriched over time in all four stomachs. Additionally, weighted gene co-expression network analysis (WGCNA) categorized a total of 5,486 genes into 10 different modules. The turquoise module was found to be particularly significant, containing the hub genes CCKBR, KCNQ1, FER1L6, and A4GNT, while the blue module was enriched with hub genes PAK6, TRIM29, ADGRF4, TGM1, and TMEM79. KEGG enrichment analysis revealed that both the turquoise and blue modules were involved in various metabolic pathways, including gastric acid secretion, sphingolipid metabolism, and pancreatic secretion, among others. Overall, this study aims to establish a molecular foundation for understanding the physiological functions of the rumen, reticulum, omasum, and abomasum in yaks. It further aims to elucidate the critical roles of these mRNAs in regulating the growth, development, and metabolism of yaks, and provide a theoretical basis for appropriate weaning and supplementary feeding practices for this species. The findings of this study contribute to a greater understanding of the unique physiology of yaks and have implications for their improved health and performance.
    Pubmed: 37808112   DOI: 10.3389/fvets.2023.1204706

    Westlund KN, et al. "Epigenetic HDAC5 Inhibitor Reverses Craniofacial Neuropathic Pain in Mice.." The journal of pain, 2023.
    The authors' data suggests that HDAC5 plays a significant role as an epigenetic factor in the persistence of chronic trigeminal neuropathic pain. This is supported by their study of RNA alterations, TG neuronal excitability, and pain-related behaviors. At week 3, treatment with an HDAC5 inhibitor successfully restores RNA balance, which persists for 10 weeks. However, increased levels of response to wound healing and chronic inflammation RNAs remain. Overall, these findings highlight the potential of HDAC5 as a target for managing chronic neuropathic pain.
    Pubmed: 37777035   DOI: 10.1016/j.jpain.2023.09.015

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare